Researchers are exploring various approaches to understand and treat prostate cancer, including engineering the disease in vitro and developing new therapies such as CAR-T cells. Studies are investigating ways to enhance the efficacy and safety of these treatments, including localized delivery of IL-12 and targeting specific proteins. The goal of this research appears to be to improve outcomes for prostate cancer patients, although the specific methods and results are still being studied and reported.